ClinicalTrials.Veeva

Menu

Borderline COVID-19 PCR Test Result

J

Jessa Hospital

Status

Completed

Conditions

Virus
Covid19

Treatments

Diagnostic Test: SARS-CoV-2 PCR

Study type

Observational

Funder types

Other

Identifiers

NCT04636294
f/2020/166

Details and patient eligibility

About

Follow-up of patients with a borderline PCR result. Data of patients that were re-tested within 96 hours after receiving a borderline COVID-19 PCR result are reviewed.

This is a retrospective study.

Enrollment

30,000 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Every individual that delivers a nasopharyngeal lysate for SARS-CoV-2 RNA determination by PCR.

Exclusion criteria

  • Patients without a previous borderline COVID-19 PCR result within 96 hours are excluded for the follow-up study.

Trial design

30,000 participants in 1 patient group

COVID-19 suspected by symptoms, after high-risk contact or after a borderline PCR result.
Treatment:
Diagnostic Test: SARS-CoV-2 PCR

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems